Trial Profile
Real-world Dosing Patterns of Rivaroxaban in the United States (RIVA-D)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms RIVA-D
- Sponsors Bayer
- 10 Aug 2017 New trial record